News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
40 Under 40
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
40 Under 40
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
706,467 Results
Type
Article (41190)
Company Profile (250)
Press Release (665027)
Multimedia
Podcasts (56)
Webinars (12)
Section
Business (206677)
Career Advice (2125)
Deals (35850)
Drug Delivery (102)
Drug Development (81614)
Employer Resources (175)
FDA (16263)
Job Trends (14957)
News (348961)
Policy (32963)
Tag
Academia (2591)
Accelerated approval (5)
Adcomms (20)
Allergies (85)
Alliances (49787)
ALS (91)
Alzheimer's disease (1392)
Antibody-drug conjugate (ADC) (126)
Approvals (16261)
Artificial intelligence (257)
Autoimmune disease (23)
Automation (16)
Bankruptcy (367)
Best Places to Work (11692)
BIOSECURE Act (19)
Biosimilars (106)
Biotechnology (176)
Bladder cancer (79)
Brain cancer (27)
Breast cancer (280)
Cancer (2271)
Cardiovascular disease (174)
Career advice (1779)
Career pathing (30)
CAR-T (151)
Cell therapy (427)
Cervical cancer (19)
Clinical research (66379)
Collaboration (839)
Company closure (1)
Compensation (533)
Complete response letters (20)
COVID-19 (2627)
CRISPR (40)
C-suite (246)
Cystic fibrosis (100)
Data (2207)
Decentralized trials (2)
Denatured (20)
Depression (46)
Diabetes (271)
Diagnostics (6406)
Digital health (18)
Diversity (8)
Diversity, equity & inclusion (45)
Drug discovery (121)
Drug pricing (101)
Drug shortages (27)
Duchenne muscular dystrophy (96)
Earnings (87736)
Editorial (41)
Employer branding (21)
Employer resources (149)
Events (113442)
Executive appointments (737)
FDA (17529)
Fibrodysplasia Ossificans Progressiva (1)
Friedreich's ataxia (4)
Frontotemporal dementia (7)
Funding (756)
Gene editing (104)
Generative AI (19)
Gene therapy (307)
GLP-1 (725)
Government (4514)
Grass and pollen (4)
Guidances (67)
Healthcare (18998)
Huntington's disease (23)
IgA nephropathy (27)
Immunology and inflammation (117)
Indications (29)
Infectious disease (2770)
Inflammatory bowel disease (138)
Inflation Reduction Act (8)
Influenza (52)
Intellectual property (97)
Interviews (333)
IPO (16649)
IRA (40)
Job creations (3675)
Job search strategy (1508)
Kidney cancer (10)
Labor market (38)
Layoffs (473)
Leadership (18)
Legal (8034)
Liver cancer (75)
Lung cancer (321)
Lymphoma (154)
Machine learning (7)
Management (58)
Manufacturing (316)
MASH (69)
Medical device (13468)
Medtech (13473)
Mergers & acquisitions (19745)
Metabolic disorders (695)
Multiple sclerosis (82)
NASH (16)
Neurodegenerative disease (91)
Neuropsychiatric disorders (27)
Neuroscience (1937)
NextGen: Class of 2025 (6572)
Non-profit (4519)
Now hiring (39)
Obesity (371)
Opinion (213)
Ovarian cancer (75)
Pain (88)
Pancreatic cancer (84)
Parkinson's disease (150)
Partnered (21)
Patents (235)
Patient recruitment (112)
Peanut (46)
People (58234)
Pharmaceutical (65)
Pharmacy benefit managers (20)
Phase I (20683)
Phase II (29224)
Phase III (21788)
Pipeline (1208)
Policy (142)
Postmarket research (2606)
Preclinical (8798)
Press Release (66)
Prostate cancer (107)
Psychedelics (33)
Radiopharmaceuticals (253)
Rare diseases (381)
Real estate (5965)
Recruiting (67)
Regulatory (22512)
Reports (46)
Research institute (2350)
Resumes & cover letters (361)
Rett syndrome (5)
RNA editing (5)
RSV (42)
Schizophrenia (71)
Series A (132)
Series B (85)
Service/supplier (11)
Sickle cell disease (52)
Special edition (15)
Spinal muscular atrophy (148)
Sponsored (29)
Startups (3624)
State (2)
Stomach cancer (13)
Supply chain (69)
Tariffs (40)
The Weekly (34)
Vaccines (704)
Venture capitalists (41)
Weight loss (239)
Women's health (36)
Worklife (16)
Date
Today (97)
Last 7 days (900)
Last 30 days (2626)
Last 365 days (32915)
2025 (10819)
2024 (35465)
2023 (40357)
2022 (51465)
2021 (55991)
2020 (54429)
2019 (46946)
2018 (35377)
2017 (32490)
2016 (31930)
2015 (37950)
2014 (31729)
2013 (26778)
2012 (29009)
2011 (29674)
2010 (27736)
Location
Africa (750)
Alabama (53)
Alaska (7)
Arizona (235)
Arkansas (14)
Asia (38650)
Australia (6342)
California (6154)
Canada (2023)
China (531)
Colorado (271)
Connecticut (279)
Delaware (149)
Europe (83233)
Florida (914)
Georgia (208)
Idaho (57)
Illinois (541)
India (25)
Indiana (309)
Iowa (11)
Japan (164)
Kansas (104)
Kentucky (24)
Louisiana (10)
Maine (62)
Maryland (895)
Massachusetts (4597)
Michigan (220)
Minnesota (392)
Mississippi (2)
Missouri (81)
Montana (27)
Nebraska (25)
Nevada (63)
New Hampshire (63)
New Jersey (1746)
New Mexico (28)
New York (1753)
North Carolina (987)
North Dakota (8)
Northern California (2689)
Ohio (208)
Oklahoma (14)
Oregon (34)
Pennsylvania (1379)
Puerto Rico (12)
Rhode Island (33)
South America (1124)
South Carolina (23)
South Dakota (1)
Southern California (2313)
Tennessee (101)
Texas (908)
United States (23252)
Utah (182)
Virginia (146)
Washington D.C. (64)
Washington State (552)
West Virginia (3)
Wisconsin (54)
706,467 Results for "thermogenesis holdings inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Business
ThermoGenesis Holdings Announces Third Quarter 2023 Financial Results and Provides Corporate Update
ThermoGenesis Holdings, Inc. reported financial and operating results for the third quarter ended September 30, 2023, and provided a corporate business update.
November 13, 2023
·
8 min read
Press Releases
Medpace Holdings, Inc. Reports First Quarter 2025 Results
April 22, 2025
·
17 min read
Press Releases
Aspire Biopharma Holdings, Inc., to Present at the Emerging Growth Conference on Thursday, April 17
April 14, 2025
·
3 min read
Biotech Bay
ThermoGenesis Holdings to Present at the H.C. Wainwright 25th Annual Global Investment Conference
ThermoGenesis Holdings, Inc. today announced that Chris Xu , Ph.D., Chief Executive Officer, will present a company overview on Wednesday, September 13, at 4:30 pm ET.
September 6, 2023
·
1 min read
Press Releases
Adagio Medical Holdings, Inc. Receives FDA Breakthrough Device Designation for the vCLASTM Cryoablation System
April 17, 2025
·
5 min read
Business
ThermoGenesis Holdings to Announce Financial Results for the Third Quarter Ended September 30, 2023, and Provide a Corporate Strategic Update
ThermoGenesis Holdings, Inc. (Nasdaq: THMO), a market leader in automated cell processing tools and services in the cell and gene therapy field, today announced that the Company will release its financial results for the third quarter ended September 30, 2023, and provide a corporate strategic update on Thursday, November 13, 2023, after the close of trading.
November 8, 2023
·
3 min read
Business
ThermoGenesis Holdings Announces Second Quarter 2023 Financial Results and Provides Corporate Update
ThermoGenesis Holdings, Inc., a market leader in automated cell processing tools and services in the cell and gene therapy field, reported financial and operating results for the second quarter ended June 30, 2023, and provided a corporate business update.
August 10, 2023
·
8 min read
Press Releases
Organogenesis Holdings Inc. to Report First Quarter of Fiscal Year 2025 Financial Results on May 8, 2025
April 8, 2025
·
1 min read
Press Releases
BioLab Holdings, Inc. Receives IRB Approval for Trial on Membrane Wrap™
February 13, 2025
·
2 min read
Press Releases
Aspire Biopharma Holdings, Inc., Announces Public Listing on Nasdaq
February 20, 2025
·
5 min read
1 of 70,647
Next
